LOS ANGELES, April 2, 2013 (GLOBE NEWSWIRE) -- MediSwipe Inc. ( www.MediSwipe.com ) (OTCBB:MWIP), a data management, patient security and financial products company for the medicinal marijuana and health care industry, today announced the filing of its annual report. The Company issued the following Letter To Shareholders from the CEO, B. Michael Friedman.
As Chief Executive Officer of MediSwipe, it is with great pleasure that I address you today and review our corporate growth over 2012 as well as outline our vision for 2013. This year promises to be an opportunistic time for our company, and we intend to continue to inform our shareholders, potential investors and customers regularly of our progress. Our first priority is to aggressively roll out and commercialize our MediSwipe suite of applications and products for the medicinal marijuana and healthcare sectors as we continue to gain momentum into 2013 and the future.Major Highlights of 2012 Last year was a challenging one, with changes in banking legislation that no longer permitted merchant processing for the medicinal sector. This posed a challenge to the foundation of our primary business model. Over the last several months, we sought vertical markets, which would be both sustainable and profitable while allowing us to best use our resources and banking network. Our initial strategy, to provide financing for elective surgeries, for patients through our seasoned banking relationships, provided the springboard for our new application development. These are now being launched in several dispensaries, provisional centers and to caregivers with approved states with medicinal legislation. We are happy to report that we have completed the development of the Patient and Caregiver Data Management System. Also the MediCredit Patient cards, a part of this system will provide enhanced data management for the industry and patients. We shall continue to provide innovative data management solutions.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts